Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:LIVR
Date4/2014
Raised
Post IPO Valuation

General Information

Websitelumenapharma.com
Twitter@LumenaPharma
CategoryBioTech
Phone858-461-0694
Emailinfo@lumenapharma...
Employees
Founded2011

Offices

San Diego, USA
12531 High Bluff Drive
Suite 110
San Diego, CA, 92130
USA

People

President & CEO
Observer
Observer

Funding

TOTAL $68M
FUNDING TOTAL $68M
Series A, 5/2013
Pappas Ventures
RiverVest
Alta Partners
$23M
Series B, 3/2014
New Enterprise Associates
Adage Capital Management
RA Capital Management
Pappas Ventures
RiverVest
Alta Partners
$45M
DEBT TOTAL $2.55M
Debt, 5/2012
$2.55M

Tags

Lumena Pharmaceuticals

Lumena Pharmaceuticals is developing oral therapeutics for rare liver diseases to improve liver function, relieve disease symptoms and dramatically impact patient health. The company’s clinical-stage product candidates carry a reduced risk of systemic toxicities by selectively targeting a transporter in the intestine and are designed to be minimally absorbed in the body. Lumena’s lead candidate, LUM001, has been extensively evaluated in other indications across 12 clinical studies in more than 1,400 subjects. Because of the extensive preclinical and clinical data package for a compound at this stage in development, LUM001 is positioned to rapidly progress through the clinic in pediatric and adult patients with several types of cholestatic liver disease. While Lumena’s primary focus is to develop novel treatments for patients with rare liver diseases, the company’s therapeutic approach also has promising potential in the treatment of metabolic diseases affecting the liver, a significant and growing health problem in children and adults.

Recent Milestones

Videos

Screenshots

Lumena Pharmaceuticals screenshot
Above: Lumena Pharmaceuticals
Uploaded: 5/10/13

Stock Price

Sources

  1. SEC (sec.gov) [edit]
  2. Lumena Pharmaceuticals Announces $23 Million Series A Financing (reuters.com) [edit]
  3. Lumena Pharmaceuticals Secures $45M in Series B Financing (finsmes.com) [edit]
Edit This Page
Last Edited 4/4/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy